Search
NEWS

Baseline Characteristics of the Intention-to-Treat KARISMA Population

By A Mystery Man Writer

Baseline Characteristics of the Intention-to-Treat KARISMA Population

Baseline characteristics of participants of the RATIO case-control study

Baseline Characteristics of the Intention-to-Treat KARISMA Population

Signe BORGQUIST, Associate Professor, Senior Consultant, MD, PhD, Division of Oncology and Pathology/Clinical Trial Unit

Baseline Characteristics of the Intention-to-Treat KARISMA Population

Yvonne WENGSTRÖM, Professor (Full), OCN, PhD, Professor, Karolinska Institutet, Solna, KI, Nursing Division

Baseline Characteristics of the Intention-to-Treat KARISMA Population

Description of included studies and populations.

Baseline Characteristics of the Intention-to-Treat KARISMA Population

Baseline Characteristics of the Intention-to-Treat Population

Baseline Characteristics of the Intention-to-Treat KARISMA Population

Demographic characteristics, health behaviors, and socioeconomic status

Baseline Characteristics of the Intention-to-Treat KARISMA Population

Sara MARGOLIN, MD PhD, MD, PhD, Karolinska Institutet, Solna, KI, Department of Clinical Science and Education, Södersjukhuset

Baseline Characteristics of the Intention-to-Treat KARISMA Population

Remote intensive management to improve antiplatelet adherence in acute myocardial infarction: a secondary analysis of the randomized controlled IMMACULATE trial

Baseline Characteristics of the Intention-to-Treat KARISMA Population

Yvonne WENGSTRÖM, Professor (Full), OCN, PhD, Professor, Karolinska Institutet, Solna, KI, Nursing Division

Baseline Characteristics of the Intention-to-Treat KARISMA Population

community trials.pptx

Baseline Characteristics of the Intention-to-Treat KARISMA Population

Antibiotics, Free Full-Text